User:ECuebas/Sandbox

ECuebas Sandbox

Fundraising and advocacyJDRF's largest fundraising event in the U.S. is the Walk to Cure Diabetes. Events are held across the country to raise awareness about type 1 diabetes and raise funds to be put toward research.[7]

JDRF's Children Congress is its premier advocacy event and is held every two years in Washington, D.C. Children ranging from age 4 to 17 are selected from each state to become their state's delegate in Washington. Delegates then head to Washington to meet with their representatives to tell their stories and advocate for increased federal funding and support for type 1 diabetes research.[8]

[edit] ResearchJDRF funds research that is aimed at improving the lives of people with type 1 diabetes today and in the future. JDRF focuses on research that seeks to: stop or slow the disease’s progression in people who are newly diagnosed; reverse the disease and its complications in those who have lived with it for years; prevent type 1 in people at risk and in future generations; and improve treatments for type 1 diabetes and provide better tools to achieve tight blood glucose control for people at all stages of the disease.

JDRF research can be categorized in three main areas:[9]

Cure, which includes: Replacement and Regeneration Research (replacing or regenerating the beta cells that produce insulin) Immune Research (reversing and preventing the immune system attack that causes type 1 diabetes)

Treat, which includes:

Artificial Pancreas Project Research (closing the loop between continuous glucose sensing technologies and insulin pump technologies)

Glucose Control Therapy Research (improving people’s lives by enabling them to maintain better control of their blood sugar by development of either new devices or therapies)

Complications Prevention Research (stopping or reversing the progression of complications in people with diabetes, such as eye or kidney disease—and treating these conditions in the people who already have them)

Diabetic Eye Disease Research

Prevent, which includes:

Prevention Research into the environmental and genetic causes of the disease. JDRF has both pre-autoimmunity and post-autoimmunity strategies aimed at minimizing and/or eliminating common triggers of the disease.

Currently, JDRF is funding more than 53 human clinical trials, several of which are in the advanced stages of clinical testing needed before Food and Drug Administration approvals are required.